Mainthan Palendira (@palendira) 's Twitter Profile
Mainthan Palendira

@palendira

ID: 2898906336

calendar_today14-11-2014 02:56:58

240 Tweet

286 Followers

268 Following

ICB - the journal (@immunolcellbiol) 's Twitter Profile Photo

"Nobody else was in the least bit interested... Well, if you try going to a symposium today on tumor immunology, you canโ€™t get in the room." Reflections on tumour immunology in Australia with Rajiv Khanna, Prof Delia Nelson & Prof Ian Frazer bit.ly/48g5lKQ

Mainthan Palendira (@palendira) 's Twitter Profile Photo

Excited to see this work from the lab get into preprint. Shows why mapping cellular interactions in tissues can be very informative!

ABC News (@abcnews) 's Twitter Profile Photo

Richard Scolyer is at the forefront of melanoma treatment and research, but a devastating cancer diagnosis of his own has made him the self-described "patient zero" in a new frontier of brain cancer treatment. ab.co/3t0YSmY

Chris Oโ€™Brien Lifehouse (@coblh) 's Twitter Profile Photo

๐‘๐ž๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ข๐ฌ๐ข๐ง๐  ๐Ž๐ซ๐š๐ฅ ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž: $2.5 ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐‡๐Œ๐‘๐‚ ๐†๐ซ๐š๐ง๐ญ ๐…๐ฎ๐ž๐ฅ๐ฌ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐š๐ง๐ ๐ฅ๐š๐ฎ๐ง๐œ๐ก ๐จ๐Ÿ ๐“๐ก๐ž ๐‚๐ž๐ง๐ญ๐ซ๐ž ๐จ๐Ÿ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐„๐ฑ๐œ๐ž๐ฅ๐ฅ๐ž๐ง๐œ๐ž ๐…๐จ๐ซ ๐€๐ฉ๐ฉ๐ฅ๐ข๐ž๐ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง

๐‘๐ž๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ข๐ฌ๐ข๐ง๐  ๐Ž๐ซ๐š๐ฅ ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ซ๐ž: $2.5 ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐‡๐Œ๐‘๐‚ ๐†๐ซ๐š๐ง๐ญ ๐…๐ฎ๐ž๐ฅ๐ฌ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐š๐ง๐ ๐ฅ๐š๐ฎ๐ง๐œ๐ก ๐จ๐Ÿ ๐“๐ก๐ž ๐‚๐ž๐ง๐ญ๐ซ๐ž ๐จ๐Ÿ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐„๐ฑ๐œ๐ž๐ฅ๐ฅ๐ž๐ง๐œ๐ž ๐…๐จ๐ซ ๐€๐ฉ๐ฉ๐ฅ๐ข๐ž๐ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง
Mainthan Palendira (@palendira) 's Twitter Profile Photo

Congratulations @ProfRScolyerMIA and Professor Georgina Long AO (Bluesky @gvlongphdmd)! Well and truly deserved recognition for all your amazing work! You both have been great leaders and wonderful mentors! So proud to be part of the team you lead!

Mainthan Palendira (@palendira) 's Twitter Profile Photo

Passionate about #spatialbiology? Like to work with highly productive research teams? Come join us at Sydney Cytometry in this exciting new role - Senior Cytometry Specialistย - Spatial Biology usyd.wd3.myworkdayjobs.com/USYD_EXTERNAL_โ€ฆ

Thomas Ashhurst (@tomash_1) 's Twitter Profile Photo

New Spatial Biology specialist position open in our core facility Sydney Cytometry Australia. We have #Xenium #CosMx & #CytAssist (i.e. #Visium) for spatial transcriptomics & #Hyperion platform for multiplex antibody imaging. Check out the job link below usyd.wd3.myworkdayjobs.com/en-US/USYD_EXTโ€ฆ

New Spatial Biology specialist position open in our core facility <a href="/SydneyCytometry/">Sydney Cytometry</a> Australia. We have #Xenium #CosMx &amp; #CytAssist (i.e. #Visium) for spatial transcriptomics &amp; #Hyperion platform for multiplex antibody imaging. Check out the job link below usyd.wd3.myworkdayjobs.com/en-US/USYD_EXTโ€ฆ
Mainthan Palendira (@palendira) 's Twitter Profile Photo

A great opportunity awaits someone who is passionate about #spatialbiology ! Come join us at Sydney Cytometry and work with amazing scientists on campus. Local or overseas please contact if interested.

Arutha K (@aruthak) 's Twitter Profile Photo

#Multiomics2024 in Brisbane, December 1-3. We have an amazing speaker line up spanning #omics #oncology #immunology #compbio #AI and #patientadvocacy Register at multiomics2024.org

#Multiomics2024 in Brisbane, December 1-3.

We have an amazing speaker line up spanning #omics #oncology #immunology #compbio #AI and #patientadvocacy

Register at multiomics2024.org
Dr Camelia Quek (@cameliaquek) 's Twitter Profile Photo

I am thrilled to announce that our latest #research on #adolescents and #youngadult patients with #melanoma is published with Springer Nature in Nature Communications. I am thankful to the team at Melanoma Institute Australia ๐Ÿ“Œ Read and share here: nature.com/articles/s4146โ€ฆ

Xinyu Bai (@xinyubaicath) 's Twitter Profile Photo

Thrilled to see our paper identifying immunosuppressive subtypes in #adolescent and #youngadult #melanoma patients resistant to #Immunotherapy published online. Proud to contribute to #AYAcancer research and advance our understanding in the fight against melanoma. #CancerResearch

Human Immunology News (@humanimmunenews) 's Twitter Profile Photo

A research team including Dr. Dr Camelia Quek and Xinyu Bai identified two immune checkpoint inhibitor-resistant spatiotypes in adolescent and young adult patients with melanoma showing stroma-infiltrating lymphocytes that were distinct from the adult TME. go.nature.com/44gu8gx

A research team including Dr. <a href="/CameliaQuek/">Dr Camelia Quek</a> and Xinyu Bai identified two immune checkpoint inhibitor-resistant spatiotypes in adolescent and young adult patients with melanoma showing stroma-infiltrating lymphocytes that were distinct from the adult TME. 
go.nature.com/44gu8gx
Professor Georgina Long AO (Bluesky @gvlongphdmd) (@profglongmia) 's Twitter Profile Photo

So proud of our work The Netherlands Cancer Institute Melanoma Institute Australia for #Nadina trial. #neoadjuvant #checkpoint #immunotherapy 68% decrease risk of progression/recurrence & death vs adjuvant anti-pd1. Multidisciplinary teamwork-great for patients with macroscopic stage 3 melanoma. Published today in NEJM

So proud of our work <a href="/NKI_nl/">The Netherlands Cancer Institute</a> <a href="/MelanomaAus/">Melanoma Institute Australia</a> for #Nadina trial. #neoadjuvant #checkpoint #immunotherapy  68% decrease risk of progression/recurrence &amp; death vs adjuvant anti-pd1. Multidisciplinary teamwork-great for patients with macroscopic stage 3 melanoma. Published today in NEJM